Navigating the Complexities of Ph Negative ALL - Part XIV

Speciality: Oncology


Speaker:

Dr. Sumeet Mirgh | Assistant Professor - Adult Hematolymphoid and BMT

Dr. Anjan Shreshtha | Assistant Professor - Department of Hematology

Dr. Meet Kumar | Consultant - Hemato-Oncologist

Description:

A warm welcome to all the medical professionals in this exciting learning session on managing Ph negative Acute lymphoblastic leukemia in adults.

Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach complete remission.

Ph-positive ALL is a special type of ALL in which a genetic mutation is observed in the Philadelphia chromosome. In the case of Ph-negative ALL, genetic disparities are also observed and most importantly in Ph neg ALL there is a disproportionate survival rate among the patients.

Managing Ph neg ALL often becomes difficult, however, the procedures of management of Philadelphia chromosome (Ph)–negative acute lymphoblastic leukemia (ALL) have changed dramatically in recent years leading to a positive vibe for the situation.
 
Therefore,  have overall knowledge regarding the management of Ph negative ALL. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A US health panel advises starting mammograms at age 40 rather than 50.

2.

Morning Immunotherapy Does Not Boost Lung Cancer Survival

3.

New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.

4.

Antitumor mRNA-based vaccines show potential against gastric cancer metastasis

5.

Cardiopulmonary fitness is key for helping breast cancer patients manage post-diagnosis symptoms, say researchers


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot